143 related articles for article (PubMed ID: 29898328)
1. Dysmetabolic iron overload syndrome.
Deugnier Y; Bardou-Jacquet É; Lainé F
Bull Acad Natl Med; 2016 Feb; 200(2):327-333. PubMed ID: 29898328
[TBL] [Abstract][Full Text] [Related]
2. Dysmetabolic iron overload syndrome (DIOS).
Deugnier Y; Bardou-Jacquet É; Lainé F
Presse Med; 2017 Dec; 46(12 Pt 2):e306-e311. PubMed ID: 29169710
[TBL] [Abstract][Full Text] [Related]
3. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
Lainé F; Ruivard M; Loustaud-Ratti V; Bonnet F; Calès P; Bardou-Jacquet E; Sacher-Huvelin S; Causse X; Beusnel C; Renault A; Bellissant E; Deugnier Y;
Hepatology; 2017 Feb; 65(2):465-474. PubMed ID: 27685251
[TBL] [Abstract][Full Text] [Related]
5. Dysmetabolic Iron Overload in Metabolic Syndrome.
Sachinidis A; Doumas M; Imprialos K; Stavropoulos K; Katsimardou A; Athyros VG
Curr Pharm Des; 2020; 26(10):1019-1024. PubMed ID: 32000639
[TBL] [Abstract][Full Text] [Related]
6. Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome.
Bardou-Jacquet E; Lainé F; Morcet J; Perrin M; Guyader D; Deugnier Y
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):418-21. PubMed ID: 24557330
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
8. Dietary iron overload induces visceral adipose tissue insulin resistance.
Dongiovanni P; Ruscica M; Rametta R; Recalcati S; Steffani L; Gatti S; Girelli D; Cairo G; Magni P; Fargion S; Valenti L
Am J Pathol; 2013 Jun; 182(6):2254-63. PubMed ID: 23578384
[TBL] [Abstract][Full Text] [Related]
9. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
10. Liver iron overload is associated with elevated SHBG concentration and moderate hypogonadotrophic hypogonadism in dysmetabolic men without genetic haemochromatosis.
Gautier A; Lainé F; Massart C; Sandret L; Piguel X; Brissot P; Balkau B; Deugnier Y; Bonnet F
Eur J Endocrinol; 2011 Aug; 165(2):339-43. PubMed ID: 21646287
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease.
Murali AR; Gupta A; Brown K
Hepatol Res; 2018 Feb; 48(3):E30-E41. PubMed ID: 28593739
[TBL] [Abstract][Full Text] [Related]
12. Assessment of plasma catecholamines in patients with dysmetabolic iron overload syndrome.
Hanna HWZ; Baz HN; Al-Kzayer LFY; El Haddad HE; El-Mougy F
J Appl Biomed; 2022 Dec; 20(4):141-145. PubMed ID: 36708719
[TBL] [Abstract][Full Text] [Related]
13. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
[TBL] [Abstract][Full Text] [Related]
14. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy.
Brigant F; Hautefeuille V; Dadban A; Lok C; Nguyen-Khac E; Chaby G
Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437295
[TBL] [Abstract][Full Text] [Related]
15. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
[TBL] [Abstract][Full Text] [Related]
16. Does iron overload in metabolic syndrome affect macrophage profile? A case control study.
Lahaye C; Gladine C; Pereira B; Berger J; Chinetti-Gbaguidi G; Lainé F; Mazur A; Ruivard M
J Trace Elem Med Biol; 2021 Sep; 67():126786. PubMed ID: 34022567
[TBL] [Abstract][Full Text] [Related]
17. Dietary iron overload enhances Western diet induced hepatic inflammation and alters lipid metabolism in rats sharing similarity with human DIOS.
Fujiwara S; Izawa T; Mori M; Atarashi M; Yamate J; Kuwamura M
Sci Rep; 2022 Dec; 12(1):21414. PubMed ID: 36496443
[TBL] [Abstract][Full Text] [Related]
18. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
[TBL] [Abstract][Full Text] [Related]
19. Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation?
Moris W; Verhaegh P; Jonkers D; Deursen CV; Koek G
Semin Liver Dis; 2019 Nov; 39(4):476-482. PubMed ID: 31330553
[TBL] [Abstract][Full Text] [Related]
20. Both hepatic and body iron stores are increased in dysmetabolic iron overload syndrome. A case-control study.
Jézéquel C; Lainé F; Laviolle B; Kiani A; Bardou-Jacquet E; Deugnier Y
PLoS One; 2015; 10(6):e0128530. PubMed ID: 26030828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
